Relative to MCD_C-Kit−-BMC mice, hepatic steatosis (Fig. 6E, F), lobular inflammation (Fig. 6E, G) and fibrosis (Fig. 6E, H) were significantly alleviated in MCD_C-Kit+-BMC mice (p < 0.05). Here, KIT is linked to fatty liver disease.